Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy
Frank Bridoux(Université de Poitiers), Christian Combe(Université de Bordeaux), Bruno Moulin(Université de Strasbourg), Jean‐Paul Fermand(Sorbonne Université), Karine Augeul-Meunier(Centre Hospitalier Universitaire de Saint-Étienne), Bertrand Arnulf(Université Paris Cité), Alexandre Karras(Délégation Paris 5), Bertrand Knebelmann(Hôpital Necker-Enfants Malades), Arnaud Jaccard(Centre Hospitalier Universitaire de Limoges), Brigitte Kolb(Centre Hospitalier Universitaire de Reims), É. Alamartine, Bertrand Joly(Centre Hospitalier Sud Francilien), Sylvie Chevret(Saint Louis University Hospital), Pierre‐Louis Carron(Centre Hospitalier Universitaire de Grenoble), Brigitte Pegourié(Centre Hospitalier Universitaire de Grenoble), Lotfi Benboubker, Bruno Royer(Centre Hospitalier Universitaire Amiens-Picardie), Nolwenn Rabot(Centre Hospitalier Universitaire de Tours), T. Lamy(Centre Hospitalier Universitaire de Rennes), Alain Wynckel(Centre Hospitalier Universitaire de Reims), Cécile Vigneau(Inserm), Marie‐Noelle Péraldi(Assistance Publique – Hôpitaux de Paris)
Cited by 164
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k